Nivolumab in non-small cell lung cancer: A novel case of an erythema annulare centrifugum-like eruption

Polytimi Sidiropoulou; Themis Sgontzou; Ioanna Kostara; Dimitrios Sgouros; Barbara Theologi; Eftychia Zouridaki; Georgios Kontochristopoulos; Dimitris Rigopoulos; Alexander J Stratigos

doi:10.1016/j.jdcr.2019.04.007

Nivolumab in non-small cell lung cancer: A novel case of an erythema annulare centrifugum-like eruption

JAAD Case Rep. 2019 Jun 26;5(7):572-575. doi: 10.1016/j.jdcr.2019.04.007. eCollection 2019 Jul.

Authors

Polytimi Sidiropoulou¹, Themis Sgontzou¹, Ioanna Kostara², Dimitrios Sgouros¹, Barbara Theologi³, Eftychia Zouridaki⁴, Georgios Kontochristopoulos⁴, Dimitris Rigopoulos¹, Alexander J Stratigos¹

Affiliations

¹ 1st Department of Dermatology-Venereology, National and Kapodistrian University of Athens, Faculty of Medicine, "A. Sygros" Hospital for Cutaneous & Venereal Diseases, Athens, Greece.
² 1st Department of Respiratory Medicine, National and Kapodistrian University of Athens, Faculty of Medicine, "Sotiria" General Hospital, Athens, Greece.
³ Pathology Department, "A. Sygros" Hospital for Cutaneous & Venereal Diseases, Athens, Greece.
⁴ State Department of Dermatology-Venereology, "A. Sygros" Hospital for Cutaneous & Venereal Diseases, Athens, Greece.

No abstract available

Keywords: AC, adenocarcinoma; EAC, erythema annulare centrifugum; NSCLC, non–small cell lung cancer; PD-1, programmed cell death–1; drug reaction; erythema annulare centrifugum; immune checkpoint inhibitors; immunotherapy; irAEs, immune-related adverse events; lung adenocarcinoma; nivolumab; programmed cell death-1 inhibitors; skin reaction.

Publication types

Case Reports